Search Results
Found 1 results
510(k) Data Aggregation
(57 days)
OsteoCNX Bone Graft Substitute is intended for use as a bone void filler to fill voids or gaps of the skeletal system not intrinsic to the stability of the bony structure (extremities, pelvis, posterior lateral spine). OsteoCNX Bone Graft Substitute is also indicated for use in the treatment of surgically created osseous defects created from traumatic injury to the bone. OsteoCNX Bone Graft Substitute must be wetted with bone marrow aspirate or, when used in the posterolateral spine, autologous bone must also be added (50/50 ratio by volume). Following placement in the bony void or gap (defect), OsteoCNX Bone Graft Substitutes are resorbed with bone during the healing process
Not Found
I am sorry, but the provided text does not contain any information about acceptance criteria or a study that proves a device meets such criteria. The document is an FDA clearance letter for a device called "OsteoCNX" and primarily discusses regulatory information and the device's indications for use. No performance metrics, study details, or ground truth information are present.
Ask a specific question about this device
Page 1 of 1